SOLV · 8-K · 20260805PR000045

Market Demand Trends

Solventum Corp · 2026-08-05 · Importance 48 · Surprise 40 · In source text

Solventum reported second-quarter organic sales growth of 9.5%, reflecting volume and product mix across all reportable segments. The company said advance orders placed ahead of enterprise-resource-planning cutovers contributed to quarterly demand. MedSurg sales increased 12.7% to $1.372 billion, including Advanced Wound Care growth of 14.9% to $537 million and Infection Prevention and Surgical Solutions growth of 11.3% to $836 million; Dental Solutions increased 17.0% to $396 million, while Health Information Systems grew 4.4% to $354 million.

Key facts

Impact estimates

metricdirectionstageexpectedbasis
net_incomenegativecommitted-0.0%The Solventum Foundation announced a $350,000 grant to America’s ToothFairy to expand access for more than 100,000 children and caregivers…